46
Participants
Start Date
March 31, 2007
Primary Completion Date
December 31, 2010
Study Completion Date
August 31, 2011
Doxil
Open label study of Doxil given as 30 mg/m2 every three weeks by itself in cycle 1
Avastin
First agent (Doxil) will be following by Avastin 15 mg/kg on cycle 2 and every cycle thereafter until disease progression
New York University Cancer Institute, New York
University of New Mexico, Albuquerque
New Mexico Cancer Care Associates, Santa Fe
Collaborators (1)
Genentech, Inc.
INDUSTRY
NYU Langone Health
OTHER
New Mexico Cancer Research Alliance
OTHER